These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Pharma-clinics. The drug of the month. Celecoxib (Celebrex)]. Scheen AJ Rev Med Liege; 2001 Jan; 56(1):53-5. PubMed ID: 11256140 [TBL] [Abstract][Full Text] [Related]
3. What have we learned from the large outcomes trials of COX-2 selective inhibitors? The rheumatologist's perspective. Hochberg MC Clin Exp Rheumatol; 2001; 19(6 Suppl 25):S15-22. PubMed ID: 11695246 [TBL] [Abstract][Full Text] [Related]
4. Celecoxib, a selective cyclooxygenase-2 inhibitor for the treatment of rheumatoid arthritis and osteoarthritis. Goldenberg MM Clin Ther; 1999 Sep; 21(9):1497-513; discussion 1427-8. PubMed ID: 10509845 [TBL] [Abstract][Full Text] [Related]
5. Cyclooxygenase-2 specificity and its clinical implications. Lefkowith JB Am J Med; 1999 May; 106(5B):43S-50S. PubMed ID: 10390127 [TBL] [Abstract][Full Text] [Related]
6. COX-2 selective inhibitors in the treatment of arthritis: a rheumatologist perspective. Hochberg MC Curr Top Med Chem; 2005; 5(5):443-8. PubMed ID: 15974939 [TBL] [Abstract][Full Text] [Related]
7. [Clinical pharmacology of the selective COX-2 inhibitors]. Burian M; Geisslinger G Orthopade; 2003 Dec; 32(12):1078-87. PubMed ID: 14655004 [TBL] [Abstract][Full Text] [Related]
8. Drug switching patterns among patients with rheumatoid arthritis and osteoarthritis using COX-2 specific inhibitors and non-specific NSAIDs. Zhao SZ; Wentworth C; Burke TA; Makuch RW Pharmacoepidemiol Drug Saf; 2004 May; 13(5):277-87. PubMed ID: 15133778 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of cyclooxygenase-2-specific inhibitors. Cannon GW; Breedveld FC Am J Med; 2001 Feb; 110 Suppl 3A():6S-12S. PubMed ID: 11173044 [TBL] [Abstract][Full Text] [Related]
10. Update on clinical developments with celecoxib, a new specific COX-2 inhibitor: what can we expect? Geis GS Scand J Rheumatol Suppl; 1999; 109():31-7. PubMed ID: 10422544 [TBL] [Abstract][Full Text] [Related]
11. Celecoxib for the treatment of pain and inflammation: the preclinical and clinical results. Tindall E J Am Osteopath Assoc; 1999 Nov; 99(11 Suppl):S13-7. PubMed ID: 10643176 [TBL] [Abstract][Full Text] [Related]
12. Celecoxib: a review of its use in osteoarthritis, rheumatoid arthritis and acute pain. Clemett D; Goa KL Drugs; 2000 Apr; 59(4):957-80. PubMed ID: 10804043 [TBL] [Abstract][Full Text] [Related]
14. Selective cyclooxygenase-2 inhibitors for the treatment of arthritis. Fung HB; Kirschenbaum HL Clin Ther; 1999 Jul; 21(7):1131-57. PubMed ID: 10463513 [TBL] [Abstract][Full Text] [Related]
15. Treatment of rheumatoid arthritis and osteoarthritis with COX-2-selective inhibitors: a managed care perspective. Hochberg MC Am J Manag Care; 2002 Nov; 8(17 Suppl):S502-17. PubMed ID: 12458820 [TBL] [Abstract][Full Text] [Related]
16. Are selective COX 2 inhibitors superior to traditional non steroidal anti-inflammatory drugs? Jüni P; Rutjes AW; Dieppe PA BMJ; 2002 Jun; 324(7349):1287-8. PubMed ID: 12039807 [No Abstract] [Full Text] [Related]
17. Persistence with non-selective NSAIDs and celecoxib among patients with gastroesophageal reflux disease and osteoarthritis or rheumatoid arthritis. Cryer B; Luo X; Assaf AR; Sands G; Mardekian J Curr Med Res Opin; 2011 Feb; 27(2):295-302. PubMed ID: 21142617 [TBL] [Abstract][Full Text] [Related]
18. [Celebrex: confirmed effectiveness and safety (new data)]. Nasonov EL Ter Arkh; 2001; 73(5):57-61. PubMed ID: 11517753 [No Abstract] [Full Text] [Related]
19. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. Silverstein FE; Faich G; Goldstein JL; Simon LS; Pincus T; Whelton A; Makuch R; Eisen G; Agrawal NM; Stenson WF; Burr AM; Zhao WW; Kent JD; Lefkowith JB; Verburg KM; Geis GS JAMA; 2000 Sep; 284(10):1247-55. PubMed ID: 10979111 [TBL] [Abstract][Full Text] [Related]